跳至主要内容
临床试验/JPRN-jRCT1040230010
JPRN-jRCT1040230010招募中Unknown

Development of proactive antimicrobial strategy using novel rapid test complex for microorganisms during pancreatoduodenectomy - DOREMI trial

Fujii Tsutomu0 个研究点目标入组 150 人开始时间: 2023年4月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients are scheduled to undergo pancreaticoduodenectomy.
  • Patients must be at least 20 years of age at the time of enrollment.
  • ECOG PS status 0, 1, or 2
  • The patient's consent to participate in this study was obtained.

排除标准

  • History of serious drug hypersensitivity or drug allergy.
  • Patients have obvious preoperative infection or inflammation (e.g., fever over 38.0 digree).
  • Patient has a serious underlying disease (cardiac, pulmonary, metabolic, renal, cirrhosis, bowel obstruction, etc.) and is considered by the surgeon to be at high risk (more than 5%) of surgery-related mortality.
  • Patients have dementia, psychosis, or psychiatric symptoms.
  • Other conditions that make them unsuitable for the study as determined by the study investigator(s).

研究者

发起方
Fujii Tsutomu

相似试验